Wuhan Easy Diagnosis Biomedicine Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 84.60% vs -56.23% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 102.88% vs -227.75% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "70.70",
          "val2": "38.30",
          "chgp": "84.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.30",
          "val2": "-80.70",
          "chgp": "83.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.50",
          "val2": "0.30",
          "chgp": "733.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.80",
          "val2": "-62.60",
          "chgp": "102.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-188.40%",
          "val2": "-2,397.70%",
          "chgp": "220.93%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -24.25% vs -53.20% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -382.33% vs -61.56% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "264.90",
          "val2": "349.70",
          "chgp": "-24.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-153.30",
          "val2": "-70.70",
          "chgp": "-116.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "1.50",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.10",
          "val2": "-16.50",
          "chgp": "143.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-75.10",
          "val2": "26.60",
          "chgp": "-382.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-787.60%",
          "val2": "-423.70%",
          "chgp": "-36.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

70.70

38.30

84.60%

Operating Profit (PBDIT) excl Other Income

-13.30

-80.70

83.52%

Interest

0.20

0.30

-33.33%

Exceptional Items

2.50

0.30

733.33%

Consolidate Net Profit

1.80

-62.60

102.88%

Operating Profit Margin (Excl OI)

-188.40%

-2,397.70%

220.93%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 84.60% vs -56.23% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 102.88% vs -227.75% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

264.90

349.70

-24.25%

Operating Profit (PBDIT) excl Other Income

-153.30

-70.70

-116.83%

Interest

1.00

1.50

-33.33%

Exceptional Items

7.10

-16.50

143.03%

Consolidate Net Profit

-75.10

26.60

-382.33%

Operating Profit Margin (Excl OI)

-787.60%

-423.70%

-36.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -24.25% vs -53.20% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -382.33% vs -61.56% in Dec 2024

All Annual Results